No Data
No Data
Craig-Hallum Sticks to Their Buy Rating for Avid Bioservices (CDMO)
Avid Bioservices to Participate at Upcoming Investor Conferences
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high
Avid Bioservices Currently Up 11 Consecutive Days, on Track for Longest Winning Streak on Record -- Data Talk
Avid Bioservices, Inc. (CDMO) is currently at $8.37, up $0.12 or 1.45% --Would be highest close since March 6, 2024, when it closed at $8.79 --Currently up 11 consecutive days; up 30.99% over this p
How Novo-Catalent Deal Affects Halozyme (HALO)?
Avid Bioservices Is Maintained at Outperform by RBC Capital
Avid Bioservices Is Maintained at Outperform by RBC Capital
Express News | RBC Capital Maintains Outperform on Avid Bioservices, Raises Price Target to $8